By updating the genetic code inside mRNA vaccines every year, scientists can keep population-level immunity aligned with ...

[NEW YORK] Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the ...

The strategic partnership that yielded one of history's most successful vaccines reached a turning point this week. Pfizer ...

The profit-sharing continues, but the commercial tide has shifted, and Pfizer is now chasing a different growth engine. Its $10 billion acquisition of Metsera, clinched after a bidding war, signals a ...

The clarification from the German biotech company comes on the heels of a Bloomberg report that Pfizer is considering selling ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than ​five years after both ...

The WifOR Institute’s ‘handprint’ quantifies positive socioeconomic impact of pharma products, positing a sustainability ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

A significant strategic pivot is underway in the pharmaceutical sector, creating notable market reactions. Pfizer, the American pharmaceutical giant, has dec ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.